![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 60, Issue 6, 1375-1382, December 2001
Department of Pharmacology (A.-D.Q., R.A.N.), University of North
Carolina, Chapel Hill, North Carolina; and Departments of Pharmacology
(A.C.Z., P.A.I.) and Medicine (P.A.I.), University of California at San
Diego, La Jolla, California
The recently cloned canine P2Y11 receptor
(cP2Y11) and its human homolog (hP2Y11) were
stably expressed in Chinese hamster ovary cells (CHO-K1) and 1321N1
human astrocytoma cells, and their agonist selectivities and coupling
efficiencies to phospholipase C and adenylyl cyclase were assessed.
Adenosine triphosphate nucleotides were much more potent and
efficacious at the hP2Y11 receptor than their corresponding
diphosphates in promoting both inositol phosphate and cyclic AMP
accumulation. In contrast, adenosine diphosphate nucleotides were
considerably more potent at the cP2Y11 receptor than their
corresponding triphosphate analogs. The tri- versus diphosphate
specificity of the two receptors was further confirmed in studies using
Ca2+ mobilization as a measure of receptor activation under
conditions that minimized nucleotide degradation. Moreover,
2-methylthioadenosine-5'-triphosphate and
2-methylthioadenosine-5'-diphosphate were 58- and 75-fold more potent
than ATP and ADP, respectively, at the cP2Y11 receptor compared with only 2- to 3-fold more potent at the hP2Y11
receptor. Mutational analysis revealed that the change of Arg-265,
which is located at the juxtaposition of transmembrane domain 6 and the
third extracellular loop in the hP2Y11 receptor, to
glutamine in the cP2Y11 receptor is at least partly
responsible for the diphosphate selectivity but not the increased
sensitivity to 2-thioether-substituted adenine nucleotides at the
canine receptor. These results imply a key role for a positively
charged arginine residue in contributing to the recognition of
extracellular nucleotides by the P2Y11 receptor and perhaps
other P2Y receptors.
This article has been cited by other articles:
|
|
 |
|
  K. Hoffmann, Y. Baqi, M. S. Morena, M. Glanzel, C. E. Muller, and I. von Kugelgen Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 648 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Rayment, V. Ralevic, D. A. Barrett, R. Cordell, and S. P. H. Alexander A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release FASEB J, February 1, 2007; 21(2): 577 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Rossi, W. C. Salmon, M. Chua, and C. W. Davis Calcium signaling in human airway goblet cells following purinergic activation Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L92 - L98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shen, C. I. Seye, M. Wang, G. A. Weisman, P. A. Wilden, and M. Sturek Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells Mol. Pharmacol., November 1, 2004; 66(5): 1265 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Fries, T. H. Wheeler-Schilling, E. Guenther, and K. Kohler Expression of P2Y1, P2Y2, P2Y4, and P2Y6 Receptor Subtypes in the Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3410 - 3417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Herold, A.-D. Qi, T. K. Harden, and R. A. Nicholas Agonist Versus Antagonist Action of ATP at the P2Y4 Receptor Is Determined by the Second Extracellular Loop J. Biol. Chem., March 19, 2004; 279(12): 11456 - 11464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. White, T. E. Webb, and M. R. Boarder Characterization of a Ca2+ Response to Both UTP and ATP at Human P2Y11 Receptors: Evidence for Agonist-Specific Signaling Mol. Pharmacol., June 1, 2003; 63(6): 1356 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vial and R. J. Evans P2X1 Receptor-Deficient Mice Establish the Native P2X Receptor and a P2Y6-Like Receptor in Arteries Mol. Pharmacol., December 1, 2002; 62(6): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Torres, A. C. Zambon, and P. A. Insel P2Y11 Receptors Activate Adenylyl Cyclase and Contribute to Nucleotide-promoted cAMP Formation in MDCK-D1 Cells. A MECHANISM FOR NUCLEOTIDE-MEDIATED AUTOCRINE-PARACRINE REGULATION J. Biol. Chem., March 1, 2002; 277(10): 7761 - 7765. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
